# DataMeds AI Inc. (MEDS)

Source: https://www.quantisnow.com/company/MEDS
Generated: 2026-11-17T04:44:00.504Z

- Ticker: MEDS
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Other Pharmaceuticals
- SEC CIK: 0002030763
- Website: https://wellgisticshealth.com

## About

DataMEDS AI, Inc. (NASDAQ:MEDS), formerly Wellgistics Health, Inc., is a healthcare company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units through its health information technology platforms to deliver a better experience for consumers and providers. Headquartered in Tampa, Fla., DataMEDS incorporates its EinsteinRx artificial intelligence platform and PharmacyChain blockchain-enabled smart contracts platform into the Health Lives Here mobile application from Tollo Health, LLC, and its pharmacy-related Corexa Health subsidiary provides pharmacy dispensing and pharmacy-related services, including distribution of products developed by Tollo Health. DataMEDS also owns Helomics Corporation, a Pittsburgh, PA -based commercial clinical molecular diagnostics laboratory focused on the ChemoFx Assay chemotherapy selection diagnostics test that aims to help oncologists make chemotherapy treatment decisions.

## Latest MEDS news and filings

- 2026-11-17 02:00 UTC [Market Insight] [UPDATING ORIGINAL RELEASE DataMEDS AI Releases CEO Letter](https://www.quantisnow.com/insight/updating-original-release-datameds-ai-releases-ceo-letter-6795278)
- 2026-11-16 21:15 UTC [Market Insight] [DataMEDS AI Releases CEO Letter](https://www.quantisnow.com/insight/datameds-ai-releases-ceo-letter-6794081)
- 2026-11-13 15:20 UTC [Market Insight] [DataMEDS AI Reports 50% Sequential Revenue Growth in Third Quarter 2026 From Second Quarter 2026, Delivers Net Profit Per Share of $2.72 and Provides Business Update](https://www.quantisnow.com/insight/datameds-ai-reports-50-sequential-revenue-growth-in-third-quarter-6789750)
- 2026-11-05 11:00 UTC [Market Insight] [DataMEDS AI Signs MOU to Deploy Health Lives Here GLP-1 Patient Management Program with Florida-Based HMO](https://www.quantisnow.com/insight/datameds-ai-signs-mou-to-deploy-health-lives-here-glp-1-6773964)
- 2026-11-03 23:18 UTC [Market Insight] [DataMEDS AI Announces Termination of Second Amended and Restated Letter of Intent](https://www.quantisnow.com/insight/datameds-ai-announces-termination-of-second-amended-and-restated-letter-6770701)
- 2026-11-02 11:00 UTC [Market Insight] [DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee](https://www.quantisnow.com/insight/datameds-ai-enters-into-agreement-for-commercial-supply-of-six-6765831)
- 2026-10-23 10:45 UTC [Market Insight] [DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network](https://www.quantisnow.com/insight/datameds-ai-establishes-health-lives-here-community-respiratory-program-for-6755764)
- 2026-10-22 12:00 UTC [Conference Announcement] [Datavault AI Signs Non-Binding Letter of Intent to Acquire a 19.9% Equity Stake in DataMEDS AI in Consideration of an Expanded Technology License](https://www.quantisnow.com/insight/datavault-ai-signs-non-binding-letter-of-intent-to-acquire-a-6754450)
- 2026-10-22 11:40 UTC [Market Insight] [DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies](https://www.quantisnow.com/insight/datameds-ai-enters-into-amended-and-restated-loi-to-license-6754391)
- 2026-10-20 10:00 UTC [Market Insight] [DataMeds Regains Compliance With NASDAQ Listing Standards](https://www.quantisnow.com/insight/datameds-regains-compliance-with-nasdaq-listing-standards-6751214)
- 2026-10-16 10:00 UTC [Market Insight] [DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap](https://www.quantisnow.com/insight/datameds-applauds-fdas-proposed-interim-access-policy-for-compounding-using-6748531)
- 2026-10-14 13:48 UTC [Market Insight] [DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform](https://www.quantisnow.com/insight/datameds-si-licenses-us-rights-to-reboot-health-ais-direct-to-consumer-6746233)
- 2026-10-13 10:00 UTC [Market Insight] [DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division](https://www.quantisnow.com/insight/datameds-si-provides-business-update-on-clia-lab-helomics-and-6743832)
- 2026-10-12 10:00 UTC [Market Insight] [DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers](https://www.quantisnow.com/insight/datameds-si-announces-helomics-receives-medicaid-coverage-policy-for-chemofxr-6743396)
- 2026-10-05 10:00 UTC [Market Insight] [Datameds AI Files DBAs Datameds SI And Corexa Health SI And Reminds Shareholders Of Record As Of August 7, 2026 Of Dream Bowl Meme Coin I Payment](https://www.quantisnow.com/insight/datameds-ai-files-dbas-datameds-si-and-corexa-health-si-6735737)
- 2026-10-01 16:39 UTC [These Stocks Roar into October with Fresh Catalysts](https://www.quantisnow.com/insight/these-stocks-roar-into-october-with-fresh-catalysts-6732055)
- 2026-10-01 10:00 UTC [Market Insight] [DataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly Revenue](https://www.quantisnow.com/insight/datameds-ais-corexa-pharmacy-surpasses-1-million-in-monthly-revenue-6731149)
- 2026-09-28 15:51 UTC [Public Offering] [4 Explosive Stories Enter the Investor Spotlight](https://www.quantisnow.com/insight/4-explosive-stories-enter-the-investor-spotlight-6727491)
- 2026-09-28 10:00 UTC [Market Insight] [DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application](https://www.quantisnow.com/insight/datameds-ai-and-tollo-health-announce-launch-of-health-lives-6726905)
- 2026-09-25 10:00 UTC [Market Insight] [DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit](https://www.quantisnow.com/insight/datameds-ai-to-present-at-2026-national-telehealth-and-virtual-6725898)
- 2026-09-21 10:00 UTC [Market Insight] [DataMEDS AI Unveils New Corporate Website](https://www.quantisnow.com/insight/datameds-ai-unveils-new-corporate-website-6721068)
- 2026-09-18 10:00 UTC [Market Insight] [DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked](https://www.quantisnow.com/insight/datameds-ai-litigation-settlement-extinguishes-19-million-in-liabilities-and-6719908)
- 2026-09-15 20:05 UTC [Market Insight] [DataMEDS, AI. Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from Axe Compute](https://www.quantisnow.com/insight/datameds-ai-acquires-helomics-ai-cancer-diagnostics-lab-and-precision-6716035)
- 2026-09-15 12:30 UTC [Axe Compute Sells Helomics AI Cancer Diagnostics Lab Business to DataMEDS AI, Completing Transition to Neocloud GPU-as-a-Service platform](https://www.quantisnow.com/insight/axe-compute-sells-helomics-ai-cancer-diagnostics-lab-business-to-6715514)
- 2026-09-08 10:00 UTC [Market Insight] [Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout](https://www.quantisnow.com/insight/datameds-ai-and-tollo-health-partner-with-the-nfl-alumni-6707197)
- 2026-08-27 13:30 UTC [Market Insight] [CORRECTION FROM SOURCE: DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)](https://www.quantisnow.com/insight/correction-from-source-datameds-ai-and-tollo-health-announce-fall-6696688)
- 2026-08-27 12:55 UTC [Market Insight] [DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)](https://www.quantisnow.com/insight/datameds-ai-and-tollo-health-announce-fall-2026-cold-flu-6696605)
- 2026-08-17 13:00 UTC [Market Insight] [DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update](https://www.quantisnow.com/insight/datameds-ai-reports-second-quarter-2026-financials-and-provides-business-6684550)
- 2026-08-14 21:25 UTC [Market Insight] [DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of August 7, 2026](https://www.quantisnow.com/insight/datameds-ai-announces-its-board-of-directors-approved-september-9-6683752)
- 2026-08-12 11:40 UTC [Market Insight] [DataMeds AI Provides Update on Corexa Health's Pharmacy Division](https://www.quantisnow.com/insight/datameds-ai-provides-update-on-corexa-healths-pharmacy-division-6677022)
- 2026-08-10 12:30 UTC [Market Insight] [DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division](https://www.quantisnow.com/insight/datameds-ai-renames-pharmacy-subsidiaries-corexa-pharmacy-and-corexa-tech-6672925)
- 2026-08-06 12:15 UTC [Market Insight] [DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date](https://www.quantisnow.com/insight/datameds-ai-reiterates-501-dream-bowl-meme-coin-token-to-6667567)
- 2026-08-05 12:30 UTC [Market Insight] [DataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here"](https://www.quantisnow.com/insight/datameds-ai-to-be-featured-in-person-on-fox-business-claman-6664184)
- 2026-07-31 12:30 UTC [Market Insight] [DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid(R) and Galactovid(TM)](https://www.quantisnow.com/insight/datameds-ais-corexa-pharmacy-launches-tollo-healths-tollovidr-and-galactovidtm-6657270)
- 2026-07-29 14:15 UTC [Market Insight] [DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License](https://www.quantisnow.com/insight/datameds-ai-expands-license-with-datavault-ai-for-data-driven-6653055)
- 2026-07-29 13:05 UTC [Dividends] [Datavault AI Expands Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License With DataMeds AI](https://www.quantisnow.com/insight/datavault-ai-expands-data-driven-outcome-healthcare-focused-blockchain-and-data-6652985)
- 2026-07-27 13:00 UTC [Market Insight] [DataMEDS AI Announces Updated August 7, 2026 Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders](https://www.quantisnow.com/insight/datameds-ai-announces-updated-august-7-2026-record-date-for-6649232)
- 2026-07-22 12:15 UTC [Market Insight] [DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets](https://www.quantisnow.com/insight/datameds-ai-officially-begins-trading-under-stock-symbol-meds-on-6644731)
- 2026-07-21 13:31 UTC [Conference Announcement] [WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC.](https://www.quantisnow.com/insight/wellgistics-health-inc-officially-changes-corporate-name-to-datameds-ai-6643536)
- 2026-06-04 12:00 UTC [Market Insight] [SCIENTURE to Present at The Small Cap Showcase & WTR Insights on June 9, 2026, in NYC](https://www.quantisnow.com/insight/scienture-to-present-at-the-small-cap-showcase-wtr-insights-6588579)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/MEDS
- Earnings history: https://www.quantisnow.com/earnings/MEDS
- Dividend history: https://www.quantisnow.com/dividends/MEDS
- Insider transactions: https://www.quantisnow.com/insiders/MEDS
- Options chain: https://www.quantisnow.com/options/MEDS
- SEC 8-K filings only: https://www.quantisnow.com/company/MEDS/8-k
- RSS and alerts for MEDS: https://www.quantisnow.com/docs/rss-feeds.md
